Navigation Links
CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.

SEATTLE, Jan. 17, 2012 /PRNewswire/ -- CompleGen, Inc. announced today that they have executed a non-exclusive services agreement regarding CompleGen's XenoGene™ technology.  Boehringer Ingelheim's discovery team will apply the technology to explore targets that are not easily accessible by other discovery platforms.

CompleGen's XenoGene™ technology uses the power of genetics to identify allosteric inhibitors that are selective for specific protein targets.

"We are very pleased to be working with Boehringer Ingelheim to open pathways for therapeutics that have proved to be elusive previously," commented Pauline Gee, CompleGen's VP Business Development.

About CompleGen

CompleGen is a drug discovery company that uses its proprietary discovery platform, XenoGene™ technology to identify and develop selective inhibitors for difficult targets.  With its small molecule library, CompleGen has identified potent allosteric inhibitors for targets where other discovery platforms have failed.  These allosteric inhibitors have been shown to be efficacious and well tolerated in animals.

Pauline Gee, PhD
Vice President, Business Development
CompleGen, Inc.
1124 Columbia Street, Suite 662
Seattle, WA 98104

SOURCE CompleGen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Incisive Surgical Announces Breakthrough Peer Review Clinical Study
2. Molnlycke Health Care U.S. Announces Senior Management Change
3. Zimmer Announces Acquisition of Synvasive Technology, Inc.
4. MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit
5. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
6. Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology
7. Practice Fusion Announces New Funding to Support EMR Growth in 2012
8. LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool
9. BNA Books Announces the Publication of the 2011 Cumulative Supplement to "Pharmaceutical Law: Regulation of Research, Development, and Marketing"
10. NewCardio Announces Changes in Board of Directors and Executive Management
11. RSB Spine, LLC, Announces United States Patent Allowance
Post Your Comments:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):